Addex Therapeutics Ltd (ADXN)

NASDAQ
1.05
0.00(0.00%)
After Hours
1.16
+0.11(+10.47%)
- Real-time Data
  • Volume:
    38,665
  • Day's Range:
    1.03 - 1.14
  • 52 wk Range:
    1.03 - 10.90

ADXN Overview

Prev. Close
1.05
Day's Range
1.03-1.14
Revenue
-
Open
1.14
52 wk Range
1.03-10.9
EPS
-
Volume
38,665
Market Cap
-
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
28,536
P/E Ratio
-
Beta
-
1-Year Change
-89.59%
Shares Outstanding
-
Next Earnings Date
Aug 01, 2022
What is your sentiment on Addex Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Addex Therapeutics Ltd News

Addex Therapeutics Ltd Company Profile

Addex Therapeutics Ltd Company Profile

Employees
27

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson’s disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellSellStrong Sell
  • Hold or sell?
    0
    • anyone has views on this stock?
      0